泌尿補充品市場 - 按類型、應用、配方、配銷通路和預測，2024 年至 2032 年

Urology Supplements Market - By Type, By Application, By Formulation, By Distribution Channel & Forecast, 2024 - 2032

出版日期: 2024年05月02日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在泌尿科疾病盛行率不斷上升和預防保健意識不斷提高的推動下，泌尿科補充劑市場規模預計在 2024 年至 2032 年期間複合年成長率為 7.4%。隨著全球人口老化和生活方式的不斷變化，泌尿道感染、腎結石和前列腺疾病等泌尿系統疾病變得更加普遍。

據通報，泌尿道感染在全球普遍存在，每年影響全球 1.5 億人。營養科學和研究的不斷進步已經確定了特定成分，例如鋸棕櫚、蔓越莓提取物和BETA-谷甾醇，這些成分因其對泌尿和前列腺健康的有益作用而聞名。

消費者對主動健康管理和泌尿問題預防措施重要性的認知不斷提高，也推動了市場的成長。泌尿科補充劑被認為是傳統藥物治療的天然和非侵入性替代品，吸引了尋求補充療法以支持泌尿科健康的個人。電子商務平台的興起和直接面對消費者的行銷策略也將有助於市場擴張。

泌尿外科補充劑產業分為類型、應用、配方、配銷通路和地區。

根據應用，由於腎臟相關疾病的盛行率不斷增加以及腎臟健康維護意識的不斷提高，腎臟健康領域的市場規模預計到 2032 年將產生可觀的收入。由蔓越莓萃取物、蒲公英根和維生素 B6 等成分配製而成的泌尿補充劑因其據稱具有支持腎功能和泌尿道健康的功效而越來越受歡迎。

片劑配方領域的泌尿補充劑產業將在預測期內成長，這得益於其便利性、易於消費和配方多功能性。片劑形式的泌尿科補充劑為消費者提供了一種便捷的方式，將因其泌尿科益處而聞名的必需營養素和草藥提取物融入他們的日常健康習慣中。片劑也因其便攜性、更長的保存期限和精確的劑量而受到青睞，這吸引了尋求直接和持續補充的消費者。

到2032 年，亞太地區泌尿保健品產業將大幅成長，原因是日本、中國和韓國人口老化加劇，這些地區容易出現與年齡相關的泌尿系統疾病，如良性前列腺增生(BPH) 和泌尿道感染。久坐的生活方式、不健康的飲食和壓力等與生活方式相關的因素日益普遍，也將導致泌尿系統疾病的增加，促使人們在該地區尋求預防措施和補充療法。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Amway
Biotexlife
Himalaya Wellness
Himalayan Organics
Natrol, LLC
Nature's Bounty
Puritan's Pride
Solaray
Theralogix
ZAHLER

簡介目錄

Product Code: 9332

Urology supplements market size is set to register a 7.4% CAGR during 2024-2032, driven by the increasing prevalence of urological conditions and the rising awareness of preventive healthcare. With the aging global population ages and evolving lifestyles, urological disorders, such as urinary tract infections, kidney stones, and prostate conditions have become more prevalent.

As per reports, urinary tract infections are globally prevalent, affecting 150 million people worldwide every year. Rising advancements in nutritional science and research have identified specific ingredients, such as saw palmetto, cranberry extract, and beta-sitosterol, known for their beneficial effects on urinary and prostate health.

Increasing consumer awareness about the importance of proactive health management and preventive measures against urological issues is also fueling the market growth. Urology supplements are perceived as natural and non-invasive alternatives to traditional pharmaceutical treatments, appealing to individuals seeking complementary therapies to support their urological health. The rise of e-commerce platforms and direct-to-consumer marketing strategies will also contribute to the market expansion.

The urology supplements industry is segmented into type, application, formulation, distribution channel and region.

Based on application, the market size from the kidney health segment is poised to generate substantial revenue by 2032 due to the increasing prevalence of kidney-related disorders and the rising awareness of kidney health maintenance. Urology supplements formulated with ingredients like cranberry extract, dandelion root, and vitamin B6 are gaining popularity for their purported benefits in supporting kidney function and urinary tract health.

Urology supplements industry from the tablets formulation segment is set to grow over the forecast period, led by its convenience, ease of consumption, and formulation versatility. Urology supplements in tablet form offer consumers a convenient way to incorporate essential nutrients and herbal extracts known for their urological benefits into their daily health routines. Tablets are also preferred for their portability, longer shelf life, and precise dosing, which appeals to consumers looking for straightforward and consistent supplementation.

Asia Pacific urology supplements industry will grow significantly through 2032, attributed to the increasing aging population across Japan, China, and South Korea, which is prone to age-related urological conditions, such as benign prostatic hyperplasia (BPH) and urinary tract infections. The growing prevalence of lifestyle-related factors like sedentary lifestyles, unhealthy diets, and stress will also contribute to the rise in urological disorders, prompting individuals to seek preventive measures and complementary therapies in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of urological disorders
  - 3.2.1.2 Advancements in product formulations and delivery systems
  - 3.2.1.3 Increasing emphasis on preventive healthcare
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Potential interactions and side effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Multi-ingredient
5.3 Single ingredient

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Urinary tract infections
6.3 Kidney health
6.4 Prostate health
6.5 Bladder health
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Capsules
7.3 Softgels
7.4 Tablets
7.5 Liquid
7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Brick & mortar
8.3 E-commerce

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa